Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pediatrix Medical (MD) Short term Debt: 2009-2024

Historic Short term Debt for Pediatrix Medical (MD) over the last 11 years, with FY2024 value amounting to $20.5 million.

  • Pediatrix Medical's Short term Debt rose 3145.36% to $25.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $25.3 million, marking a year-over-year increase of 3145.36%. This contributed to the annual value of $20.5 million for FY2024, which is 3776.57% up from last year.
  • Per Pediatrix Medical's latest filing, its Short term Debt stood at $20.5 million for FY2024, which was up 3776.57% from $14.9 million recorded in FY2023.
  • Pediatrix Medical's 5-year Short term Debt high stood at $20.5 million for FY2024, and its period low was $2.5 million during FY2021.
  • For the 4-year period, Pediatrix Medical's Short term Debt averaged around $13.2 million, with its median value being $14.9 million (2022).
  • In the last 5 years, Pediatrix Medical's Short term Debt skyrocketed by 49831.33% in 2022 and then increased by 10.07% in 2023.
  • Annual analysis of 4 years shows Pediatrix Medical's Short term Debt stood at $2.5 million in 2021, then soared by 498.31% to $14.9 million in 2022, then increased by 0.1% to $14.9 million in 2023, then surged by 37.77% to $20.5 million in 2024.
  • Its last three reported values are $20.5 million in FY2024, $14.9 million for FY2023, and $14.9 million during FY2022.